Program listing for APLI Day 1 Panel 7 on injunctive relief, covering a global perspective for enforcing patents and building portfolios.

Silimed secured a Munich PI against Polytech over EP2581193, halting polyurethane-coated implant manufacture and sales in Germany amid parallel UPC action.

São Paulo Court of Justice reinstated an injunction in a med-tech patent dispute, granting suspensive effect to J&J’s extraordinary appeals against Scitech.

David Medical and its subsidiary face Silag/Johnson & Johnson patent suits in China, with claimed damages raised to RMB 161.26 million.

São Paulo court restored a temporary injunction in Johnson & Johnson v Scitech, reimposing Brazil’s ban on sales of Altus electric staplers.

BRPTO’s 2026 patent landscape maps satellite energy and space propulsion trends, showing Brazil’s growing filings and the dominance of research institutions.

Fulbright Medical’s Shanghai Stock Exchange IPO was terminated after extensive Johnson & Johnson patent litigation, including multiple infringement suits and rising damages claims.

Silimed becomes the first Brazilian UPC claimant, suing Polytech in Hamburg over EP’193 implant technology and seeking pan‑European injunctive relief.

On-demand Global IP Spotlight briefing on Latin America covering AI, SEPs, pharmaceuticals, patent prosecution and oppositions, with takeaways for U.S. stakeholders.

Silimed becomes the first Brazilian claimant at the UPC, suing Polytech in Hamburg over EP2581193 and building on German entitlement wins.

Global settlement of pertuzumab biosimilar disputes across the U.S., UPC, the Netherlands and Brazil, highlighting Brazil’s key validity win and UPC order.

The Brazilian Court of Appeal has upheld a preliminary injunction for ZTE against Samsung, reinforcing patent exclusivity in 5G Standard Essential Patent disputes.

This BRPTO study analyzes 6,300 patent applications to map green innovation in Brazilian agriculture, highlighting biofertilizers and international cooperation.

Recent US lawsuits against AI meeting assistants highlight legal risks regarding voice data consent, offering crucial parallels for Brazil's LGPD framework.

O artigo analisa a Lei nº 15.325/2026 e a formalização do profissional multimídia no Brasil, destacando o reconhecimento jurídico e os desafios práticos.

Brazil’s Law 15,325/2026 recognizes multimedia professionals and influencers but faces criticism for educational requirements and lack of oversight mechanisms.

Learn how the Mercosur–EU agreement may reshape Brazil’s IP landscape, strengthening enforcement and influencing patents, trademarks, designs and trade secrets.

A comprehensive outlook on the 2026 regulatory landscape for Brazil's Life Sciences sector, covering CMED pricing, Anvisa's sandbox, and clinical trials.

The Brazilian Superior Court of Justice (STJ) clarifies the application of atypical coercive measures for monetary enforcement under Article 139, IV.

The EU Digital Omnibus simplifies GDPR and AI Act rules, shifting toward a risk-based approach to foster innovation while protecting fundamental data rights.

The BRPTO implements a structural reform under Decree #12,803/2025, focusing on technical specialization and governance to improve IP examination quality in Brazil.

Brazil implements new pricing criteria for technology transfer in Productive Development Partnerships (PDPs) to ensure transparency and SUS fiscal responsibility.

Brazil’s Ministry of Health's SUS Digital call repositions it as an innovation orchestrator, detailing institutional, legal, and IP implications for the HealthTech ecosystem.